
Maydine M 2mg/500mg Tablet SR
Marketer
Delcure Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Maydine M 2mg/500mg Tablet SR
Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision may lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital to diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its hypoglycemic effect. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Maydine M 2mg/500mg Tablet SR
No text provided. Please provide the text you wish to be rewritten.
Uses of Maydine M 2mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Maydine M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Maydine M 2 mg/500 mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this extended-release tablet with a meal.
Common Side effects of Maydine M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Maydine M 2mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Maydine M 2 mg/500 mg Extended-Release tablets with a meal.
How Maydine M 2mg/500mg Tablet SR works:
Maydine M 2 mg/500 mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Maydine M 2 mg/500 mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Maydine M 2 mg/500 mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Maydine M tablets (2 mg/500 mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Maydine M 2 mg/500 mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Maydine M 2 mg/500 mg Tablet SR. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
The extended-release Maydine M 2 mg/500 mg tablet requires careful administration in individuals with hepatic impairment. Dosage modification of Maydine M 2 mg/500 mg Tablet SR may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, Maydine M 2 mg/500 mg Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Maydine M 2mg/500mg Tablet SR :
Should you forget a Maydine M 2 mg/500 mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Maydine M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
